Endothelial Cell Transcytosis Assay as an In Vitro Model to Evaluate Inner Blood-Retinal Barrier Permeability
June 7th, 2022
This protocol illustrates an in vitro endothelial cell transcytosis assay as a model to evaluate inner blood-retinal barrier permeability by measuring the ability of human retinal microvascular endothelial cells to transport horseradish peroxidase across cells in caveolae-mediated transcellular transport processes.
Overview
This protocol illustrates an in vitro endothelial cell transcytosis assay as a model to evaluate inner blood-retinal barrier permeability. It measures the ability of human retinal microvascular endothelial cells to transport horseradish peroxidase across cells in caveolae-mediated transcellular transport processes.
Key Study Components
Area of Science
- Neuroscience
- Vascular Biology
- Cell Biology
Background
- Endothelial transcytosis is crucial for understanding vascular barrier integrity.
- The blood-retinal barrier (BRB) and blood-brain barrier (BBB) are selective vascular barriers.
- This assay provides a cell-based model requiring no live animals.
- It allows for the investigation of molecular regulators affecting endothelial permeability.
Purpose of Study
- To evaluate the permeability of the inner blood-retinal barrier.
- To investigate the mechanisms underlying endothelial transcytosis.
- To explore potential drug delivery across vascular barriers.
Methods Used
- Preparation of cell culture filter inserts.
- Coating inserts with gelatin solution.
- Seeding human retinal microvascular endothelial cells (HRMECs).
- Measuring transport of horseradish peroxidase across the cells.
Main Results
- The assay effectively models endothelial transcytosis.
- It provides insights into the permeability of the inner blood-retinal barrier.
- Results can inform drug delivery strategies across vascular barriers.
- Facilitates understanding of molecular mechanisms affecting barrier integrity.
Conclusions
- This protocol is a valuable tool for vascular biology research.
- It enhances understanding of BRB and BBB control mechanisms.
- Offers a platform for investigating therapeutic interventions.
Frequently Asked Questions
Executive Industry Relevance
Quantitative assessment of endothelial transcytosis using human retinal microvascular endothelial cells (HRMECs) provides a predictive in vitro model for evaluating inner blood-retinal barrier (iBRB) permeability. This assay enables mechanistic de-risking of molecular regulators affecting vascular barrier integrity, supporting early-stage target validation and drug delivery research. Its reproducibility and scalability position it as a strategic asset for portfolio triage and translational pipeline advancement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of molecular pathways regulating iBRB permeability, such as Wnt signaling.
- Supports functional validation of targets influencing endothelial transcytosis and barrier integrity.
- Facilitates mechanistic de-risking by isolating effects on clathrin- and caveolae-mediated transport.
- Provides predictive confidence for advancing vascular barrier-modulating candidates.
Screening & Assay Development
- Delivers a standardized, animal-free platform for quantifying transcellular transport across HRMEC monolayers.
- Generates reproducible, quantitative readouts (e.g., transferrin and HRP transport) for compound evaluation.
- Enables assay scalability and platform reuse for screening molecular regulators or delivery systems.
- Supports robust assay development for downstream permeability and transport studies.
Translational & Preclinical Research
- Aligns with disease-relevant models for vascular eye pathologies involving iBRB dysfunction.
- Provides continuity from discovery to preclinical validation of barrier-modulating interventions.
- Enables risk-adjusted advancement decisions based on quantitative permeability data.
- Supports translational biomarker development for vascular barrier integrity.
Pipeline & Workflow Integration
This in vitro transcytosis assay bridges early discovery and preclinical research by enabling hypothesis testing, pathway clarification, and quantitative assessment of endothelial barrier function.
- Discovery Biology: Supports mechanistic studies of molecular regulators and pathway modulators affecting iBRB permeability.
- Screening: Provides validated, reproducible readouts for compound and pathway screening.
- Analytics: Delivers quantitative measurements of transferrin and HRP transport for comparative analysis.
- Translational Research: Facilitates alignment with disease models and preclinical validation of barrier-targeted strategies.
- Enterprise Reuse: Offers a reusable, scalable platform adaptable to various vascular barrier research needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in vascular barrier research.
- Operational Value: Standardizes permeability assessment and enhances reproducibility across studies.
- Strategic Value: Informs go/no-go decisions and improves capital efficiency by de-risking early-stage candidates.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of barrier-modulating assets.
Implementation Considerations
- Requires expertise in endothelial cell culture and quantitative assay setup.
- Needs access to fluorescence plate readers and TEER measurement instrumentation.
- Demands rigorous cross-team standardization for reproducibility and data comparability.
- Adaptable to co-culture or 3D organotypic systems for enhanced physiological relevance.
- Assay sensitivity to handling, temperature, and culture conditions must be managed for reliable outputs.
Biopharma FAQs
Chapters in this video
0:04
Introduction
1:04
Culturing HRMECs
3:46
TEER Measurements
4:44
Clathrin-Mediated Transcytosis Assay Using Cy3-Transferrin
6:00
Caveolae-Mediated Transcytosis Assay Using Horse Radish Peroxidase (HRP)
7:29
Results: Visualization of Endothelial Cell Transcytosis in the Retina and In Vitro Transcytosis Assay as a Model of BRB
10:14
Conclusion
